Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Ulm
University of California, Davis
M.D. Anderson Cancer Center
University of Washington
M.D. Anderson Cancer Center
University of Miami
Gilead Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
MingSight Pharmaceuticals, Inc
Memorial Sloan Kettering Cancer Center
Aprea Therapeutics
Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
ADC Therapeutics S.A.
Bayer
MEI Pharma, Inc.
Hackensack Meridian Health
Academic and Community Cancer Research United
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Altor BioScience
Takeda
Pfizer
Ipsen
University of Nebraska
SecuraBio
SecuraBio
University of Nebraska
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hoffmann-La Roche
Medical College of Wisconsin
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Rush University Medical Center
Case Comprehensive Cancer Center
University of Washington
Takeda
Spectrum Pharmaceuticals, Inc
Hoffmann-La Roche
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
Northwestern University